There's good news, and then there's great news - and if you ask us, this is the latter. We'll get right to it, the #splunkconf24 Session Scheduler is now available. 🙌 That's right, start building your dream .conf24 agenda now.
.conf24’s Post
More Relevant Posts
-
Calyx #IRT ensures that your #RTSM requirements are fulfilled, no matter what happens during your #ClinicalTrial. Check out this case study to find out more: https://lnkd.in/dPccSHKg #Flexibility #ClinicalTrials #ChooseCalyx
Calyx IRT: Ensuring Trial Supply through Unexpected Study Changes | Calyx
calyx.dsmn8.com
To view or add a comment, sign in
-
Calyx #IRT ensures that your #RTSM requirements are fulfilled, no matter what happens during your #ClinicalTrial. Check out this case study to find out more: https://lnkd.in/gVJsgBWF #Flexibility #ClinicalTrials #ChooseCalyx
Calyx IRT: Ensuring Trial Supply through Unexpected Study Changes | Calyx
calyx.dsmn8.com
To view or add a comment, sign in
-
Calyx #IRT ensures that your #RTSM requirements are fulfilled, no matter what happens during your #ClinicalTrial. Check out this case study to find out more: https://lnkd.in/gNv7Wirs #Flexibility #ClinicalTrials #ChooseCalyx
Calyx IRT: Ensuring Trial Supply through Unexpected Study Changes | Calyx
calyx.dsmn8.com
To view or add a comment, sign in
-
Senior Business Leader | Health Services/Healthcare | Delivers Value-Based Care Strategy and Innovation at Evernorth Health Services
Peripheral vascular disease has impacted my family directly and I'm glad to see that EviCore is working to address this. Leveraging evidence and expertise to improve the safety and cost of PVD care. Download to learn more about how EviCore is enhancing PVD outcomes. #WeAreEvernorth #StrongerTogether
Enhancing Peripheral Vascular Disease Outcomes
evicore.com
To view or add a comment, sign in
-
Calyx #IRT ensures that your #RTSM requirements are fulfilled, no matter what happens during your #ClinicalTrial. Check out this case study to find out more: https://lnkd.in/gTFv_sGj #Flexibility #ClinicalTrials #ChooseCalyx
Calyx IRT: Ensuring Trial Supply through Unexpected Study Changes | Calyx
calyx.dsmn8.com
To view or add a comment, sign in
-
Calyx #IRT ensures that your #RTSM requirements are fulfilled, no matter what happens during your #ClinicalTrial. Check out this case study to find out more: https://lnkd.in/ggKw8z_R #Flexibility #ClinicalTrials #ChooseCalyx
Calyx IRT: Ensuring Trial Supply through Unexpected Study Changes | Calyx
calyx.dsmn8.com
To view or add a comment, sign in
-
Calyx #IRT ensures that your #RTSM requirements are fulfilled, no matter what happens during your #ClinicalTrial. Check out this case study to find out more: https://lnkd.in/eaESW_fP #Flexibility #ClinicalTrials #ChooseCalyx
Calyx IRT: Ensuring Trial Supply through Unexpected Study Changes | Calyx
calyx.dsmn8.com
To view or add a comment, sign in
-
Are the pets entering your practice racking up their frequent flier miles? As pet owners increasingly travel or relocate, they influence geographic shifts in vector-borne disease prevalence. Join this upcoming webinar with Dr. Wade Burton and Dr. Brian Herrin to review the landscape of vector-borne diseases in North America, how their geography and prevalence have changed, and what pathogens could emerge as a threat in the future.
IDEXX Learning Center webinar: Future Landscape of Vector-borne Diseases
learn.idexx.com
To view or add a comment, sign in
-
The answer: Attend .conf! The question: “How can I learn more about Cisco’s future plans for Splunk products?”
Event Details | .conf24 User Conference | Splunk
conf.splunk.com
To view or add a comment, sign in
-
Are the pets entering your practice racking up their frequent flier miles? As pet owners increasingly travel or relocate, they influence geographic shifts in vector-borne disease prevalence. Join this upcoming webinar with Dr. Wade Burton and Dr. Brian Herrin to review the landscape of vector-borne diseases in North America, how their geography and prevalence have changed, and what pathogens could emerge as a threat in the future.
IDEXX Learning Center webinar: Future Landscape of Vector-borne Diseases
learn.idexx.com
To view or add a comment, sign in
6,489 followers